Sunzen Biotech Banks on Twin Growth Strategy to Propel Earnings

SUNZEN Biotech Bhd (Sunzen) is shifting its focus away from its traditional animal health product business and banking on human health products and loan financing services to become the group’s new dual engines of growth in the coming years.

Group managing director Teo Yek Ming says the group will be focusing on growing its two other core businesses given the challenging business environment in the animal health product sector.

“Since the beginning of 2023, many pig farms in Malaysia have been badly hit by African swine fever. Many pigs died and it affected our animal health product business because the small pig farms were our main customers,” he tells The Edge in an interview.

Read More